Research on longevity, or fighting aging as a disease, has several things in the way of its progress. These range from technical complexity, to regulatory barriers, to negative public perceptions and misunderstandings of life extension. The largest hurdle, however, is funding. It’s difficult to deny the profound impact more funding would have on discoveries made and advances achieved in the field of aging. [1,2,3] More funding means more shots on goal, but innovation on how that funding is deployed is also desperately needed.
The current state of biomedical research funding is a fraught topic, every step of the way. In…
VitaDAO’s mission is to accelerate research and development in the longevity space by focusing on the two stakeholder groups most essential to its mission: patients and researchers. Currently, biopharma and research organizations do not represent these groups well. Biomedical research fundraising is time-consuming and its access is limited to select groups of already well funded organizations. There is a misalignment of incentives that encourage profit maximization by for-profit biopharma companies, and conversely not enough goal-oriented work is done by non-profit research organizations.
VitaDAO fixes this by coordinating the actions of for-profits and non-profits. …
VitaDAO launches through a Gnosis Auction running from June 18 to June 23. Gnosis Auction optimizes for fair and decentralized token distributions. With the launch just around the corner, this brief guide explains all you need to know to acquire VitaDAO’s governance tokens (VITA). Note, this process may take up to a few days, depending on your situation.
1️⃣ the public address of your Ethereum wallet
2️⃣ Etherum tokens (ETH) equivalent to the amount you would like to acquire VITA tokens for, plus additional ETH for gas costs (that is, transaction fees)
Unless you already have an Ethereum wallet…
For Dr. Morten Scheibye-Knudsen — associate professor at the University of Copenhagen — aging is the largest risk factor for most diseases, and damage to our genome is likely the cause of aging.
Morten is focused on exploring the physiological consequences of DNA damage and what we can do to intervene in genotoxic insults. His goal is to understand, modulate, and treat aging and age-related diseases.
David M. Wilson III is a Professor of Neurosciences at Hasselt University and Founder & CEO of Boost Scientific, with over 30 years of experience in the field of life sciences. His independent and collaborative work contributes significantly to advancing research in DNA repair, premature aging, cancer, and neurodegenerative disease.
David advises VitaDAO on its general strategy as an organization in the longevity space, and drive the project forward by acquiring and developing longevity therapeutics.
David: “That’s not a simple question, and my journey was not direct. When I began my graduate school training, I elected to pursue a career…
Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a biomedical research charity that performs and funds laboratory research dedicated to combating aging.
His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and obviate that damage.
Dr. de Grey will participate in the longevity working group and advise on the general strategy of the DAO. …
1.04 billion prescriptions
4.8 million individuals
50 years of The Danish National Health Service Prescription Database
We’re excited to introduce the opening project to be funded by VitaDAO — the world’s first decentralized intellectual property collective. The research project is led by Morten Scheibye Knudsen and carried out by the Scheibye-Knudsen Lab in Copenhagen.
VitaDAO is a new type of entity in the biotech research space, and its members will own the intellectual property assets that result from the projects it supports and funds. …
We’re a decentralized cooperative that lives in the meta-verse.
We have a single purpose:
Accelerate and democratize research into longevity therapeutics.
As humans, longevity is our final frontier
Our mortality is what separates us from the machines that we create. Biotechnology has entered a phase of exponential progress that few of us grasp — redefining what it means to be human. Web3 is at a similar point, accelerating at a superhuman pace and promising the greatest breakthroughs in open collaboration humanity has witnessed.
VitaDAO is the world’s first decentralized intellectual property collective, funding and commissioning research into human longevity.